Oxurion NV to Present at the Upcoming Ophthalmology Innovation Summit and Provide a Clinical Update at the American Academy of Ophthalmology 2018 Annual Meeting
Kort samengevat
/PRNewswire/ -- Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Prnewswire.
Lees het volledige bericht ↗